Taken together, our data prove that lumbrokinase down-regulates BPTF expression, thus alleviating the binding of BPTF to the −1384 to −1667 regions of the VEGF promoter and then inhibiting the transcriptional activation and expression of VEGF in NSCLC cells. The gene discussed is BPTF; the disease is non-small cell lung carcinoma.